These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Miller E; Andrews NJ; Waight PA; Slack MP; George RC Lancet Infect Dis; 2011 Oct; 11(10):760-8. PubMed ID: 21621466 [TBL] [Abstract][Full Text] [Related]
10. Recurrent invasive pneumococcal disease in children--host factors and vaccination response. Ingels HA Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183055 [TBL] [Abstract][Full Text] [Related]
11. Herd immunity and pneumococcal conjugate vaccine: a quantitative model. Haber M; Barskey A; Baughman W; Barker L; Whitney CG; Shaw KM; Orenstein W; Stephens DS Vaccine; 2007 Jul; 25(29):5390-8. PubMed ID: 17583392 [TBL] [Abstract][Full Text] [Related]
12. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway. Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490 [TBL] [Abstract][Full Text] [Related]
13. [Disribution of Streptococcus pneumoniae serotypes and serogroups among patients with invasive pneumococcal diseases in the Czech Republic in 1996-2003: background data for vaccination strategy]. Motlová J Epidemiol Mikrobiol Imunol; 2005 Feb; 54(1):3-10. PubMed ID: 15807381 [TBL] [Abstract][Full Text] [Related]
14. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. Whitney CG; Farley MM; Hadler J; Harrison LH; Bennett NM; Lynfield R; Reingold A; Cieslak PR; Pilishvili T; Jackson D; Facklam RR; Jorgensen JH; Schuchat A; N Engl J Med; 2003 May; 348(18):1737-46. PubMed ID: 12724479 [TBL] [Abstract][Full Text] [Related]
15. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine. Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249 [TBL] [Abstract][Full Text] [Related]
16. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep; 1997 Apr; 46(RR-8):1-24. PubMed ID: 9132580 [TBL] [Abstract][Full Text] [Related]
18. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait. Mokaddas E; Albert MJ Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356 [TBL] [Abstract][Full Text] [Related]
19. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. Hicks LA; Harrison LH; Flannery B; Hadler JL; Schaffner W; Craig AS; Jackson D; Thomas A; Beall B; Lynfield R; Reingold A; Farley MM; Whitney CG J Infect Dis; 2007 Nov; 196(9):1346-54. PubMed ID: 17922399 [TBL] [Abstract][Full Text] [Related]
20. Regional differences in serotype distribution, pneumococcal vaccine coverage, and antimicrobial resistance of invasive pneumococcal disease among German federal states. Imöhl M; Reinert RR; van der Linden M Int J Med Microbiol; 2010 Apr; 300(4):237-47. PubMed ID: 19604721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]